Skip to main content

Kenneth Ouriel, MD, MBA

President & CEO

“My commitment to academic medicine and clinical research has played a pivotal role in my professional life. Syntactx serves as the perfect outlet to take my dedication to the next level. Every day we are making significant progress to improve the quality of life of others. It is incredibly gratifying to be part of the future of healthcare.”

Dr. Ouriel, a prominent vascular surgeon, published author of more than 250 scientific articles and three textbooks, and frequent presenter at national and international conferences, has over three decades of experience in medical research. 

Dr. Ouriel entered the University of Rochester at age 16 and majored in biology and psychology.  He was elected to Phi Beta Kappa in his junior year and graduated Summa Cum Laude in 1977.  He attended the Pritzker School of Medicine at the University of Chicago where he was elected to Alpha Omega Alpha and graduated in 1981.  Dr. Ouriel began a residency in general surgery at the University of Rochester Medical Center and completed a vascular surgical fellowship in 1987. 

In 1998, Dr. Ouriel was recruited to the Cleveland Clinic as Chief of Vascular Surgery, and was promoted to Chief of Surgery in 2003 where he supervised 340 surgeons in the largest surgical department in the world.  In 2008, Dr. Ouriel served as Chief of International Operations at NewYork-Presbyterian Hospital.

Dr. Ouriel’s decades-long dedication to research, strategic relationships with key opinion leaders in the pharmaceutical and medical device industry, combined with his knowledge of medicine gives the Syntactx team a foundation that is unique in the CRO arena. Under his expert guidance the study team designs, executes, and reports the results of cutting-edge clinical trials. 

Dr. Ouriel holds a BS in Biology and Psychology from University of Rochester, an MD from University of Chicago, and an MBA from Columbia University and the London School of Business.